≡ Content Category ≡ Main Menu

Health

Editors’ Note: The following blog post originally appeared on Time.com. The New York Times reports that the Trump Administration, via the Department of Health and Human Services (HHS), is circulating a memo that seeks to define gender “on a basis that is clear, grounded in science, objective and administrable.” This definition, to potentially apply throughout several federal Read More

Torso of man in grey tank wearing breast cancer ribbon

As a health psychologist dedicated to research and clinical efforts to enhance the quality of life and care of those facing cancer, I’ve come to see the many types of support breast cancer patients seek. This work led to my founding the Bronx Oncology Living Daily (BOLD Living) Program in 2008. The program has since Read More

Recently, a generally healthy friend of mine had two small, unrelated surgeries over the course of a few months. For the first, a small operation on his hand, he received a prescription for 30 oxycodone pills. He used one the night after surgery, to make sure pain wouldn’t wake him. Over the next few days Read More

One day when I was speaking to a medical student shadowing me in my developmental pediatrics practice at the Rose F. Kennedy Children’s Evaluation and Rehabilitation Center, where I specialize in the early identification of autism, I commented that I often spend my days contending with blind spots. “How so?” he asked. I started with Read More

EMS workers lift patient into ambulance - intentionally fuzzy image

The bedrock requirement to obtain informed consent before patients may be enrolled in research has been eroding. I’ve documented the different ways and different reasons for this several times here over the years (Informed Consent for Babies: When Experts Disagree, Informed Consent in Infant Research: Ethical Problems Remain, Informed Consent in Comparative Effectiveness Research and Read More

3d render of sickle cell anemia blood cells

Editors’ Note: Dr. Caterina Minniti was invited by the New England Journal of Medicine to write an editorial about L-glutamine, a drug approved by the U.S. Food and Drug Administration (FDA) last year for the treatment of sickle-cell disease. We asked Dr. Minniti, a professor of medicine and of pediatrics at Einstein and the director Read More